不同双能CT平台间碘定量的患者自身变异性:归一化技术的评估
回顾性纳入44例在癌症随访期间分别接受双源、快速kVp切换和双层探测器双能CT腹部静脉期扫描的患者,比较肝脏、胰腺和肾脏的碘浓度及不同归一化碘浓度的患者自身变异性。碘浓度变异性在肝脏最高、肾脏最低;以总体碘负荷归一化对降低变异性的效果最好,但归一化后扫描仪类型仍显著影响肝脏和胰腺的碘浓度变异性。
要点
- 碘浓度跨平台变异性肝脏最高(22.85-29.08%)、肾脏最低(10.92-15.76%),解读随访碘值时需按组织分别看待。
- 以总体碘负荷归一化(NICALL)在各组织和各扫描仪两两比较中降低变异性的效果最好。
- 归一化后扫描仪类型仍是肝脏和胰腺碘浓度变异性的显著影响因素(F值12.26和23.78,均p<0.0001)。
核心结论
- 不同双能CT扫描仪类型间碘浓度存在组织特异性的患者自身变异性,归一化可通过减少碘分布生理波动来减轻变异性,但归一化后扫描仪类型对肝脏和胰腺碘浓度变异性仍有显著影响。
研究设计与样本
- 回顾性纳入44例癌症随访期间接受腹部静脉期双能CT的患者,分别在双源双能CT、快速kVp切换双能CT和双层探测器双能CT平台扫描,比较肝脏、胰腺和肾脏碘浓度及不同归一化碘浓度,并行纵向混合效应分析。
诊断标准与关键数值
- 碘浓度患者自身变异性肝脏最高:双源vs双层探测器28.96(14.28-46.87)%、双源vs快速kVp切换29.08(16.59-62.55)%、快速kVp切换vs双层探测器22.85(7.52-33.49)%。
- 碘浓度患者自身变异性肾脏最低:双源vs双层探测器15.76(7.03-26.1)%、双源vs快速kVp切换15.67(8.86-25.56)%、快速kVp切换vs双层探测器10.92(4.92-22.79)%。
- 归一化碘浓度NICALL在全部组织和全部扫描仪两两比较中降低碘浓度变异性的效果最好,但未降低肝脏中双源vs双层探测器及双源vs快速kVp切换的变异性。
- 归一化后扫描仪类型仍是胰腺和肝脏NICALL的显著决定因素(F值12.26和23.78,均p<0.0001)。
临床应用与阅片要点
- 临床常规影像中应考虑到双能CT扫描仪间碘定量差异可被归一化部分减轻,但对特定组织和扫描仪间比较仍有意义。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate intra-patient variability of iodine concentration (IC) between three different dual-energy CT (DECT) platforms and to test different normalization approaches.
METHODS: Forty-four patients who underwent portal venous phase abdominal DECT on a dual-source (dsDECT), a rapid kVp switching (rsDECT), and a dual-layer detector platform (dlDECT) during cancer follow-up were retrospectively included. IC in the liver, pancreas, and kidneys and different normalized ICs (NICPV:portal vein; NICAA:abdominal aorta; NICALL:overall iodine load) were compared between the three DECT scanners for each patient. A longitudinal mixed effects analysis was conducted to elucidate the effect of the scanner type, scan order, inter-scan time, and contrast media amount on normalized iodine concentration.
RESULTS: Variability of IC was highest in the liver (dsDECT vs. dlDECT 28.96 (14.28-46.87) %, dsDECT vs. rsDECT 29.08 (16.59-62.55) %, rsDECT vs. dlDECT 22.85 (7.52-33.49) %), and lowest in the kidneys (dsDECT vs. dlDECT 15.76 (7.03-26.1) %, dsDECT vs. rsDECT 15.67 (8.86-25.56) %, rsDECT vs. dlDECT 10.92 (4.92-22.79) %). NICALL yielded the best reduction of IC variability throughout all tissues and inter-scanner comparisons, yet did not reduce the variability between dsDECT vs. dlDECT and rsDECT, respectively, in the liver. The scanner type remained a significant determinant for NICALL in the pancreas and the liver (F-values, 12.26 and 23.78; both, p < 0.0001).
CONCLUSIONS: We found tissue-specific intra-patient variability of IC across different DECT scanner types. Normalization mitigated variability by reducing physiological fluctuations in iodine distribution. After normalization, the scanner type still had a significant effect on iodine variability in the pancreas and liver.
CLINICAL RELEVANCE STATEMENT: Differences in iodine quantification between dual-energy CT scanners can partly be mitigated by normalization, yet remain relevant for specific tissues and inter-scanner comparisons, which should be taken into account at clinical routine imaging.
KEY POINTS: • Iodine concentration showed the least variability between scanner types in the kidneys (range 10.92-15.76%) and highest variability in the liver (range 22.85-29.08%). • Normalizing tissue-specific iodine concentrations against the overall iodine load yielded the greatest reduction of variability between scanner types for 2/3 inter-scanner comparisons in the liver and for all (3/3) inter-scanner comparisons in the kidneys and pancreas, respectively. • However, even after normalization, the dual-energy CT scanner type was found to be the factor significantly influencing variability of iodine concentration in the liver and pancreas.
引用
- Lennartz S, Cao J, Pisuchpen N, et al. Intra-patient variability of iodine quantification across different dual-energy CT platforms: assessment of normalization techniques. Eur Radiol. 2024. PMID: 38189979. doi:10.1007/s00330-023-10560-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。